BRIEF-Emergent BioSolutions Q2 Revenue USD 234.3 Million
Reuters2026/08/05 20:08Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Aug 05 (Reuters) - Emergent BioSolutions Q2 adjusted EBITDA USD 96.5 million.
- Q2 net income USD -180.2 million
- Q2 adjusted net income USD 30.9 million
- Q2 adjusted EPS USD 0.6
- Q2 gross margin 50%
- Q2 adjusted gross margin 58%
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
This Analyst Just Discovered What’s Really Going On With XRP
TimesTabloid•2026/09/06 19:00
Mare Group issues 500,000 shares for 2025-2027 stock option and stock grant plans
Reuters•2026/09/06 18:31
Dark Defender Here’s Why Ripple CEO Can’t Say a Price for XRP
TimesTabloid•2026/09/06 18:03
Defence Therapeutics completes $9.6 million private placement at $0.55 per unit
Reuters•2026/09/06 17:14
Crypto prices
More
Bitcoin
BTC
$79,859.73
-0.13%
Ethereum
ETH
$2,491.58
+0.54%
Tether USDt
USDT
$0.9999
-0.01%
BNB
BNB
$750.13
-3.37%
XRP
XRP
$1.41
-0.53%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$105.85
+1.93%
TRON
TRX
$0.3354
+0.34%
Hyperliquid
HYPE
$87.45
+1.59%
Zcash
ZEC
$1,221.6
+19.65%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now